Iterum Therapeutics plc 8-K

What Happened

• Iterum Therapeutics plc announced on March 27, 2026 that it filed a winding-up petition in the High Court in Ireland. The court appointed Damien Murran and Jennifer McMahon of Teneo Restructuring (Ireland) Limited as Joint Provisional Liquidators. The petition is scheduled to be heard on April 13, 2026. If the court issues a winding-up order, the Joint Provisional Liquidators would be confirmed as Joint Liquidators and the company would be wound up and ultimately dissolved.

Key Details

• Filing date: March 27, 2026; High Court hearing: April 13, 2026.
• Joint Provisional Liquidators: Damien Murran and Jennifer McMahon (Teneo Restructuring (Ireland) Limited).
• Executive changes: CEO Corey Fishman and CFO Judith Matthews resigned effective immediately following the filing; executive authority passed to the Joint Provisional Liquidators upon their appointment.
• Market and financial effects: The company expects Nasdaq trading to be suspended effective March 27, 2026 and warns shareholders trading is highly speculative and could result in a significant or complete loss. The filing may trigger acceleration or increase of direct financial obligations.

Why It Matters

• For investors, this filing signals that the company is seeking to be wound up under Irish law, which could lead to liquidation of assets and dissolution if the court grants the petition. Management control has already shifted to the appointed liquidators, and key executives have left, which affects ongoing operations and any potential restructuring or asset sales. The company cautions that shareholders may recover little or nothing and that trading in its securities may not reflect any ultimate recovery.